Different breast cancer subtypes respond differently to #LKB1 signaling. For instance, while some genes like #PAK1 and #SIK2 are linked to improved survival in Triple-Negative Breast Cancer (TNBC) before chemotherapy, their impact changes after treatment.
0
0
1
0